These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 39144825)

  • 1. Challenges in overcoming advanced-stage or relapsed refractory extranodal NK/T-cell lymphoma: meta-analysis of individual patient data.
    Kim TY; Kim TJ; Han EJ; Min GJ; Jeon Y; Cho SG
    Front Oncol; 2024; 14():1362367. PubMed ID: 39144825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Post-treatment plasma EBV-DNA positivity predicts early relapse and poor prognosis for patients with extranodal NK/T cell lymphoma in the era of asparaginase.
    Wang L; Wang H; Wang JH; Xia ZJ; Lu Y; Huang HQ; Jiang WQ; Zhang YJ
    Oncotarget; 2015 Oct; 6(30):30317-26. PubMed ID: 26210287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum EBV EA-IgA and VCA-IgA antibodies can be used for risk group stratification and prognostic prediction in extranodal NK/T cell lymphoma: 24-year experience at a single institution.
    Huang Y; Rao H; Yan S; Wang F; Wu Q; Feng Y; Zhang Y
    Ann Hematol; 2017 Aug; 96(8):1331-1342. PubMed ID: 28550598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment and Prognosis of Newly Diagnosed Advanced-Stage Extranodal Natural Killer/T-Cell Lymphoma: A Single-Center Real-World Study across Two Decades.
    Wei YC; Qi F; Chen B; Zhang CG; Fang H; Zhang D; Qi SN; Chai Y; Li YX; Dong M
    Chemotherapy; 2024; 69(2):108-121. PubMed ID: 37984344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-dose extended-field radiotherapy plus chemotherapy improved survival in extranodal NK/T-cell lymphoma in a real-life setting: results from the multicenter T-Cell Brazil Project.
    de Pádua Covas Lage LA; Machado PPF; Reichert CO; Miranda E; Culler HF; da Siqueira SAC; de Oliveira Costa R; Miyashiro DR; Sanches JA; Rocha V; Chiattone CS; Pereira J
    Sci Rep; 2022 Nov; 12(1):20557. PubMed ID: 36446856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and tolerance of GELOXD/P-GEMOXD in newly diagnosed nasal-type extranodal NK/T-cell lymphoma: A multicenter retrospective study.
    Li JW; Li YJ; Zhong MZ; Liu XL; Li J; Li KL; Liu XY; Zhou F; OuYang Z; Sun ZY; Huang LJ; He JQ; Zhou H; Yi PY
    Eur J Haematol; 2018 Mar; 100(3):247-256. PubMed ID: 29194798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary site and regional lymph node involvement are independent prognostic factors for early-stage extranodal nasal-type natural killer/T cell lymphoma.
    Niu SQ; Yang Y; Li YY; Wen G; Wang L; Li ZM; Wang HY; Zhang LL; Xia YF; Zhang YJ
    Chin J Cancer; 2016 Apr; 35():34. PubMed ID: 27044275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel Immunotherapy Options for Extranodal NK/T-Cell Lymphoma.
    Hu B; Oki Y
    Front Oncol; 2018; 8():139. PubMed ID: 29761078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical characteristics and survival of extranodal natural killer/T-cell lymphoma: a single-center 12-year retrospective analysis.
    Chen Y; Luo L; Zheng X; Fu H; Yang X; Huang W; Chen L; Zheng Z; Zheng J; Yang T; Liu T; Hu J
    Leuk Lymphoma; 2020 Dec; 61(14):3306-3318. PubMed ID: 32820684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel prognostic model based on ferritin and nomogram-revised risk index could better stratify patients with extranodal natural killer/T-cell lymphoma.
    Liu X; Liang Y; Shen Z; Wei L; Yang J; Piao Y; Sang W; Li P; Wang L
    Cancer Med; 2023 May; 12(9):10660-10671. PubMed ID: 36924334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical characteristics and prognostic analysis of advanced-stage extranodal NK/T cell lymphoma].
    Wei C; Zhang Y; Wang W; Zhang L; Zhang W; Zhou DB
    Zhonghua Xue Ye Xue Za Zhi; 2020 Jun; 41(6):462-468. PubMed ID: 32654458
    [No Abstract]   [Full Text] [Related]  

  • 12. An Unusual Presentation of Midline Lethal Granuloma.
    Chin EW; Saniasiaya J; Hitam S; Hassan E; Kah Wai N
    Indian J Otolaryngol Head Neck Surg; 2024 Apr; 76(2):2137-2140. PubMed ID: 38566723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary Intestinal Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type: A Comprehensive Clinicopathological Analysis of 55 Cases.
    Yu BH; Shui RH; Sheng WQ; Wang CF; Lu HF; Zhou XY; Zhu XZ; Li XQ
    PLoS One; 2016; 11(8):e0161831. PubMed ID: 27564014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiotherapy improves survival in early stage extranodal natural killer/T cell lymphoma patients receiving asparaginase-based chemotherapy.
    Li YY; Feng LL; Niu SQ; Wang HY; Zhang LL; Wang L; Xia ZJ; Huang HQ; Xia YF; Zhang YJ; Wang XC
    Oncotarget; 2017 Feb; 8(7):11480-11488. PubMed ID: 28002792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma EBV-DNA and peripheral blood mononuclear cell EBV-DNA have disparate clinical relevance in patients with extranodal NK/T-cell lymphoma.
    Yan Z; Yao Z; Wang H; Yao S; Wang X; Gao Y; Bai B; Chu J; Zhao S; Luo X; Zhou W; Zhang J; Zhang P; Huang H; Liu Y
    J Clin Virol; 2022 Dec; 157():105320. PubMed ID: 36240675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High post-treatment serum levels of soluble programmed cell death ligand 1 predict early relapse and poor prognosis in extranodal NK/T cell lymphoma patients.
    Wang H; Wang L; Liu WJ; Xia ZJ; Huang HQ; Jiang WQ; Li ZM; Lu Y
    Oncotarget; 2016 May; 7(22):33035-45. PubMed ID: 27105512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The landscape of new drugs in extranodal NK/T-cell lymphoma.
    Wang L; Li LR; Zhang L; Wang JW
    Cancer Treat Rev; 2020 Sep; 89():102065. PubMed ID: 32653806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of extranodal NK/T-cell lymphoma: From past to future.
    Yan Z; Yao S; Wang Z; Zhou W; Yao Z; Liu Y
    Front Immunol; 2023; 14():1088685. PubMed ID: 36825002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DDGP vs. SMILE in Relapsed/Refractory Extranodal Natural Killer/T-cell Lymphoma, Nasal Type: A Retrospective Study of 54 Patients.
    Wang X; Hu J; Dong M; Ding M; Zhu L; Wu J; Sun Z; Li X; Zhang L; Li L; Wang X; Fu X; Wang G; Chen Q; Zhang M; Zhang X
    Clin Transl Sci; 2021 Jan; 14(1):405-411. PubMed ID: 33045134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extranodal NK-/T-cell lymphoma, nasal type: what advances have been made in the last decade?
    Costa RO; Pereira J; Lage LAPC; Baiocchi OCG
    Front Oncol; 2023; 13():1175545. PubMed ID: 37529691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.